In a recent transaction dated 09/30/2024, Theodore R. Samuels II, associated with Bristol-Myers Squibb (BMY), was reported to have engaged in a financial action with the company's stock. The specifics of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The relationship of Samuels to the issuer was not specified, and the action's status, whether it was a purchase, sale, or another type of transaction, was also not provided. Investors are advised to seek additional details to fully understand the implications of this event on their investment decisions.

In a recent transaction dated 09/30/2024, Theodore R. Samuels II, associated with Bristol-Myers Squibb (BMY), was reported to have engaged in a financial action with the company's stock. The specifics of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of the shares, were not disclosed in the announcement. The relationship of Samuels to the issuer was not specified, and the action's status, whether it was a purchase, sale, or another type of transaction, was also not provided. Investors are advised to seek additional details to fully understand the implications of this event on their investment decisions.